Epigenetic Age Acceleration in Frontotemporal Lobar Degeneration: A Comprehensive Analysis in the Blood and Brain

Epigenetic Age Acceleration in Frontotemporal Lobar Degeneration: A Comprehensive Analysis in the Blood and Brain

Frontotemporal lobar degeneration (FTLD) includes a heterogeneous group of disorders pathologically characterized by the degeneration of the frontal and temporal lobes. In addition to major genetic contributors of FTLD such as mutations in <i>MAPT</i>, <i>GRN</i>, and <i&g...

Bibliografski detalji
Glavni autori:	Megha Murthy, Patrizia Rizzu, Peter Heutink, Jonathan Mill, Tammaryn Lashley, Conceição Bettencourt
Format:	Članak
Jezik:	English
Izdano:	MDPI AG 2023-07-01
Serija:	Cells
Teme:	frontotemporal lobar degeneration frontotemporal dementia progressive supranuclear palsy DNA methylation aging epigenetic clock
Online pristup:	https://www.mdpi.com/2073-4409/12/14/1922

Slični predmeti

New Perspective on Parkinsonism in Frontotemporal Lobar Degeneration
od: Hee Kyung Park, i dr.
Izdano: (2013-04-01)

HnRNP Pathologies in Frontotemporal Lobar Degeneration
od: Xinwa Jiang, i dr.
Izdano: (2023-06-01)

Assessing network degeneration and phenotypic heterogeneity in genetic frontotemporal lobar degeneration by decoding FDG-PET
od: Nick Corriveau-Lecavalier, i dr.
Izdano: (2024-01-01)

Are we missing early-onset frontotemporal dementia as late-onset primary psychiatric disorder? A case series
od: Ranganath R Kulkarni, i dr.
Izdano: (2024-01-01)

Frontotemporal Dementia: A Clinical Review
od: Michał Dacka, i dr.
Izdano: (2024-02-01)

The underappreciated contribution of Oskar Fischer to the knowledge of Frontotemporal Lobar Degeneration
od: Eliasz Engelhardt, i dr.
Izdano: (2025-02-01)

Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration
od: Lucia AA Giannini, i dr.
Izdano: (2023-08-01)

CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: a cross-sectional analysis
od: Vanesa Jurasova, i dr.
Izdano: (2024-09-01)

Hemispheric asymmetries in hippocampal volume related to memory in left and right temporal variants of frontotemporal degeneration
od: Robert S. Hurley, i dr.
Izdano: (2024-04-01)

Plasma biomarkers increase diagnostic confidence in patients with Alzheimer’s disease or frontotemporal lobar degeneration
od: Daniele Altomare, i dr.
Izdano: (2024-05-01)

Boostering diagnosis of frontotemporal lobar degeneration with AI-driven neuroimaging – A systematic review and meta-analysis
od: Qiong Wu, i dr.
Izdano: (2025-01-01)

A heterozygous splicing variant IVS9-7A > T in intron 9 of the MAPT gene in a patient with right-temporal variant frontotemporal dementia with atypical 4 repeat tauopathy
od: Kohji Mori, i dr.
Izdano: (2023-08-01)

Frontotemporal lobar degeneration changes neuronal beta-frequency dynamics during the mismatch negativity response
od: Alistair Perry, i dr.
Izdano: (2024-01-01)

Distinctive autophagy/mitophagy biomarker profiles in frontotemporal lobar degeneration and Alzheimer’s disease
od: Kateřina Veverová, i dr.
Izdano: (2025-02-01)

Levodopa-Induced Facial Dystonia in a Case of Progressive Supranuclear Palsy
od: Eun Joo Chung, i dr.
Izdano: (2012-05-01)

Application of the AT(N) and Other CSF Classification Systems in Behavioral Variant Frontotemporal Dementia
od: Vasilios C. Constantinides, i dr.
Izdano: (2023-01-01)

Increase in wasteosomes (corpora amylacea) in frontotemporal lobar degeneration with specific detection of tau, TDP-43 and FUS pathology
od: Raquel Alsina, i dr.
Izdano: (2024-06-01)

Increased frontocortical microvascular raspberry density in frontotemporal lobar degeneration compared to Lewy body disease and control cases: a neuropathological study
od: Henric Ek Olofsson, i dr.
Izdano: (2025-03-01)

Boundary-based registration improves sensitivity for detecting hypoperfusion in sporadic frontotemporal lobar degeneration
od: Sylvia Mihailescu, i dr.
Izdano: (2024-08-01)

Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degenerations: Similarities in Genetic Background
od: Eva Parobkova, i dr.
Izdano: (2021-03-01)

Assessment of disease impact through health‐related quality of life measurement in primary progressive aphasia
od: Thomas Hopkins, i dr.
Izdano: (2024-10-01)

Blood-based biomarkers and plasma Aβ assays in the differential diagnosis of Alzheimer’s disease and behavioral-variant frontotemporal dementia
od: Pablo Mohaupt, i dr.
Izdano: (2024-12-01)

Simple models to understand complex disease: 10 years of progress from Caenorhabditis elegans models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration
od: Randall J. Eck, i dr.
Izdano: (2024-01-01)

Feasibility and acceptability of remote smartphone cognitive testing in frontotemporal dementia research
od: Jack Carson Taylor, i dr.
Izdano: (2023-04-01)

Phenotypically concordant distribution of pick bodies in aphasic versus behavioral dementias
od: Allegra Kawles, i dr.
Izdano: (2024-02-01)

Current clinical and research practices on frontotemporal dementia in Brazil: a national survey
od: Leonardo Cruz de Souza, i dr.
Izdano: (2023-07-01)

Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
od: Rachel Keszycki, i dr.
Izdano: (2023-06-01)

Cognitive and Behavioral Manifestations in ALS: Beyond Motor System Involvement
od: Robert Rusina, i dr.
Izdano: (2021-03-01)

Frontotemporal dementia: peculiarities of clinical variants
od: B. Klimbytė, i dr.
Izdano: (2021-12-01)

Cerebrospinal Fluid Total and Phosphorylated Tau Protein in Behavioral Variant Frontotemporal Dementia, Progressive Supranuclear Palsy, Corticobasal Syndrome and Non-Fluent Agrammatic Primary Progressive Aphasia: A Systematic Review and Meta-Analysis
od: Nikolaos Giagkou, i dr.
Izdano: (2024-08-01)

Beauty and Paintings: Aesthetic Experience in Patients with Behavioral Variant Frontotemporal Dementia When Viewing Abstract and Concrete Paintings
od: Claire Boutoleau-Bretonnière, i dr.
Izdano: (2024-05-01)

The therapeutic landscape of tauopathies: challenges and prospects
od: Jeffrey L. Cummings, i dr.
Izdano: (2023-10-01)

Transcranial direct current stimulation in semantic variant of primary progressive aphasia: a state-of-the-art review
od: Davide Norata, i dr.
Izdano: (2023-11-01)

Plasma Small Extracellular Vesicles with Complement Alterations in <i>GRN</i>/<i>C9orf72</i> and Sporadic Frontotemporal Lobar Degeneration
od: Sonia Bellini, i dr.
Izdano: (2022-01-01)

A phase 1b open‐label study of sodium selenate as a disease‐modifying treatment for possible behavioral variant frontotemporal dementia
od: Lucy Vivash, i dr.
Izdano: (2022-01-01)

Frontotemporal dementia-like disease progression elicited by seeded aggregation and spread of FUS
od: Sonia Vazquez-Sanchez, i dr.
Izdano: (2024-06-01)

Early onset frontotemporal dementia following cannabis abuse: a case report
od: Reza Moshfeghinia, i dr.
Izdano: (2023-06-01)

Exploratory Tau PET/CT with [11C]PBB3 in Patients with Suspected Alzheimer’s Disease and Frontotemporal Lobar Degeneration: A Pilot Study on Correlation with PET Imaging and Cerebrospinal Fluid Biomarkers
od: Joachim Strobel, i dr.
Izdano: (2024-07-01)

Blood Biomarkers in Frontotemporal Dementia: Review and Meta-Analysis
od: Sofia Ntymenou, i dr.
Izdano: (2021-02-01)

Hebephrenic schizophrenia as a variant of frontotemporal dementia – the true dementia praecox?
od: A.B. Medeiros, i dr.
Izdano: (2021-04-01)